Literature DB >> 31444284

FcRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages.

Wei Hong Toh1, Jade Louber1, Ismail S Mahmoud1,2, Jenny Chia3, Greg T Bass3, Steve K Dower3, Anne M Verhagen3, Paul A Gleeson4.   

Abstract

The neonatal Fc receptor (FcRn) rescues albumin and IgG from degradation following endocytosis and thereby extends the half-life of these plasma proteins. However, the pathways for the uptake of these soluble FcRn ligands, and the recycling itinerary of the FcRn-ligand complexes, have not been identified in primary cells. Here, we have defined the recycling of human albumin and IgG in primary mouse macrophages selectively expressing the human FcRn. Albumin is internalised by macropinocytosis; in the absence of FcRn, internalised albumin is rapidly degraded, while in the presence of FcRn albumin colocalises to SNX5-positive membrane domains and is partitioned into tubules emanating from early macropinosomes for delivery in transport carriers to the plasma membrane. Soluble monomeric IgG was also internalised by macropinocytosis and rapidly recycled by the same pathway. In contrast, the fate of IgG bound to surface Fcγ receptors differed from monomeric IgG endocytosed by macropinocytosis. Overall, our findings identify a rapid recycling pathway for FcRn ligands from early macropinosomes to the cell surface of primary cells.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Albumin; Macropinosome; Neonatal Fc receptor; Recycling

Mesh:

Substances:

Year:  2019        PMID: 31444284     DOI: 10.1242/jcs.235416

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Dynamic Rac1 inhibition by CYRI helps cells drink, but stops them from driving.

Authors:  Jason S King
Journal:  J Cell Biol       Date:  2021-08-17       Impact factor: 10.539

Review 2.  Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis.

Authors:  Joseph Puccini; Michael Alexander Badgley; Dafna Bar-Sagi
Journal:  Trends Cancer       Date:  2021-10-11

3.  Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.

Authors:  Yizhen Guo; Lai Wei; Sandip H Patel; Gabrielle Lopez; Madison Grogan; Mingjia Li; Tyler Haddad; Andrew Johns; Latha P Ganesan; Yiping Yang; Daniel J Spakowicz; Peter G Shields; Kai He; Erin M Bertino; Gregory A Otterson; David P Carbone; Carolyn Presley; Samuel K Kulp; Thomas A Mace; Christopher C Coss; Mitch A Phelps; Dwight H Owen
Journal:  Clin Lung Cancer       Date:  2022-01-08       Impact factor: 4.840

Review 4.  Deciphering albumin-directed drug delivery by imaging.

Authors:  Huiyu Hu; Jeremy Quintana; Ralph Weissleder; Sareh Parangi; Miles Miller
Journal:  Adv Drug Deliv Rev       Date:  2022-03-29       Impact factor: 17.873

Review 5.  From Pinocytosis to Methuosis-Fluid Consumption as a Risk Factor for Cell Death.

Authors:  Markus Ritter; Nikolaus Bresgen; Hubert H Kerschbaum
Journal:  Front Cell Dev Biol       Date:  2021-06-23

6.  LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes.

Authors:  Zhiyong Liu; Enquan Xu; Hien Tran Zhao; Tracy Cole; Andrew B West
Journal:  EMBO J       Date:  2020-08-27       Impact factor: 11.598

7.  Dynamics of intracellular neonatal Fc receptor-ligand interactions in primary macrophages using biophysical fluorescence techniques.

Authors:  Andreas Pannek; Fiona J Houghton; Anne M Verhagen; Steven K Dower; Elizabeth Hinde; Paul A Gleeson
Journal:  Mol Biol Cell       Date:  2021-11-03       Impact factor: 4.138

8.  Albumin Stimulates Epithelial Na+ Transport and Barrier Integrity by Activating the PI3K/AKT/SGK1 Pathway.

Authors:  Mandy Laube; Ulrich H Thome
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

9.  Single-Cell Transcriptomic Analysis Reveals Macrophage-Tumor Crosstalk in Hepatocellular Carcinoma.

Authors:  Yunhe Liu; Lin Zhang; Xinyi Ju; Sheng Wang; Jingbo Qie
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 10.  In Translation: FcRn across the Therapeutic Spectrum.

Authors:  Timothy Qi; Yanguang Cao
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.